Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Overweight 1Obesity 1Breast Neoplasms 1

Interventions

Exercise 6Nutrition Assessment 4Counseling 4Methods 3Caloric Restriction 3Tirzepatide 2Resistance Training 2Naltrexone 2Metformin 2Megestrol Acetate 2Exenatide 2Educational Status 2Early Intervention, Educational 2Diet 2Cognitive Behavioral Therapy 2Bupropion 2Blood Specimen Collection 2semaglutide 1licogliflozin 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Trehalase 1Tablets 1Standard of Care 1Psychology, Positive 1Propofol 1Progestins 1Patient Navigation 1Motivational Interviewing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Overweight × Biopsy, Needle × Other × Clear all
NCT04291950 2022-12-20

Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women

University of Arizona

Withdrawn
BreastOther

Breast Neoplasms, Obesity, Overweight, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡